AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Cochlear Limited (ASX:COH) Responds to US Tariff Uncertainty Amid Exemption Clause
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,Cochlear products currently benefit from a US import duty exemption,Awaiting further clarification from US Customs on 10% tariff changes,North America remains a critical export destination for Cochlear,Cochlear Limited (ASX:COH), a global...
Investors Remain Pessimistic About Neuren Pharmaceuticals Limited's (NEU) Outlook
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Neuren Pharmaceuticals reports a price-to-earnings ratio below the broader market.,The company's earnings have shown a decline, influencing its valuation.,Market expectations indicate continued financial challenges in the coming years.,Ne...
Insider Transactions at AdAlta Limited Amid Stock Movement
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Insiders at AdAlta Limited experienced a stock price decrease, affecting past transactions.,Stuart Morris made the largest recorded insider acquisition at a specific price per share.,Insider ownership remains significant, aligning closely...
Is Sonic Healthcare's (SHL) Balance Sheet Strong?
April 02, 2025 01:31 PM AEDT| By Team Kalkine MediaIs Sonic Healthcare's (SHL) Balance Sheet Strong?
Nanocap health technology company Cardiex remains stable as 'CONNEQT' integrates with Apple Health.
April 01, 2025 07:16 PM AEDT| By Team Kalkine MediaHighlights:,Cardiex (ASX:CDX) integrates its CONNEQT cardiovascular software with Apple Health for seamless health data management.,The integration enhances user experience by automatically updating health metrics in Apple’s Health Records section.,D...
Neurizon Reports Successful Outcomes for Leading Drug in 3D Brain Model Study
April 01, 2025 06:34 PM AEDT| By Team Kalkine MediaHighlights:,Neurizon Therapeutics and Tessara Therapeutics collaborate on promising neurotherapeutic research.,Lead drug candidate NUZ-001 shows neuroprotective properties and encourages neuroplasticity.,Research results to be presented at the AD/PD...
Race Oncology Gains Ethics Approval for RC220 Phase 1 Trial
April 01, 2025 04:40 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology has secured human ethics approval for its Phase 1 trial of RC220 in combination with doxorubicin.,The trial will commence at Gosford and Wyong Hospitals in Australia, with patient enrollment expected in April.,Additional eth...
Seaweed Shows Golden Promise: BPH Global’s (ASX:BP8) Latest Assay Results Spark Interest
April 01, 2025 11:44 AM AEDT| By Team Kalkine MediaHighlights,Strong mineral concentrations found in Phase 2 seaweed tests.,Gold levels reach over 123 mg/kg, significantly up from earlier results.,Findings support theory on mineral absorption in polluted waters.,BPH Global (ASX:BP8) has delivered pro...
Pro Medicus (ASX:PME) Announces Major Share Repurchase Initiative
April 01, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus plans a year-long repurchase of up to 10.4 million shares.,Goldman Sachs to oversee the share repurchase program.,The buyback represents about 10% of the shares in the specified class.,Pro Medicus (ASX:PME), a leader in medical...
While many biotech companies are scrounging for funds, Clinuvel faces criticism for having an excess of cash, according to Biocurious.
March 31, 2025 11:00 AM AEDT| By Team Kalkine MediaWhile many biotech companies are scrounging for funds, Clinuvel faces criticism for having an excess of cash, according to Biocurious.
Orthocell Secures FDA Approval for Remplir, Unveiling US Market Potential
March 29, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,FDA grants clearance to Orthocell (OCC) for nerve repair product Remplir.,Entry into the US market poised to boost Orthocell's revenue prospects.,Plans for further expansion into the EU and UK, alongside efforts in Canada and Asia.,Orthoce...
Race Oncology initiates Australian site for Phase I solid tumour trial
March 28, 2025 07:09 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology Ltd establishes an Australian clinical site for its Phase 1 trial.,The study focuses on testing RC220 in combination with chemotherapy.,Trial to assess safety, dosage, and impact on cancer progression.,Race Oncology Ltd has...
Innovative Cancer Treatment Progress: Race Oncology (ASX:RAC) Advances in Chemotherapy Reformulation
March 28, 2025 03:03 PM AEDT| By Team Kalkine MediaHighlights,Race Oncology is advancing a safer chemotherapy alternative.,Clinical,trials to,explore reduced side effects and enhanced efficacy.,Potential for improved patient safety and outcomes in cancer care.,Race Oncology is spearheading a groundbr...
Compumedics Gains Traction in China with Brain Mapping Technology
March 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Compumedics announces a new deal with Hangzhou Normal University for its Orion LifeSpan MEG system.,The agreement adds to previous installations, expanding the company’s reach in China’s neuroimaging field.,The order includes advanced neur...
Race launches initial site for Phase I trial of a cardioprotective anticancer drug.
March 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Southside Cancer Care Centre in Miranda has been established as the initial site for the Phase I trial of RC220.,The trial includes participants with advanced solid tumors across Australia, Hong Kong, and South Korea.,RC220 is developed wi...
Analyzing ResMed CDI’s (ASX:RMD) Financial and Market Performance
March 28, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,ResMed CDI (RMD) navigates a market downturn with robust financial health.,Innovation and global presence sustain ResMed’s industry dominance.,ResMed’s shares trade below historical averages, hinting at potential under-valuation.,In the ev...
Artrya Limited Achieves Milestone with FDA Clearance for Groundbreaking Cardiac Technology
March 28, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Artrya Limited (AYA) secures FDA clearance for its Salix® Coronary Anatomy.,Strategic partnerships set to boost U.S. commercialization.,New technology promises a proactive approach in coronary diagnostics.,Artrya Limited (ASX:AYA) has rece...
Healius (ASX:HLS) Charts Future with Bold Pathology Strategy and Substantial Dividend Announcement
March 27, 2025 03:40 PM AEDT| By Team Kalkine MediaHighlights,Healius,(HLS) unveils a robust Pathology Strategy with,potential,high EBIT margins.,Announces special $300 million dividend following a strategic sale.,Forecasts enhanced financial health with strategic focus on operational efficiencies.,I...
Should You Be Concerned About EBR Systems' (EBR) Debt Despite the Lack of Earnings?
March 27, 2025 03:31 PM AEDT| By Team Kalkine MediaShould You Be Concerned About EBR Systems' (EBR) Debt Despite the Lack of Earnings?
Mesoblast begins Ryoncil sales in the US as shareholders remain eager for revenue.
March 27, 2025 12:30 PM AEDT| By Team Kalkine MediaMesoblast begins Ryoncil sales in the US as shareholders remain eager for revenue.
Advertise your brand on Kalkine Media